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Abstract 
Novel coronavirus is a new addition in the family of coronaviruses and was first reported in 
December 2019 in China. SARS and MERS were the earlier forms of viruses in this family of 
viruses. The outbreak was considered a pandemic in March 2020 by WHO. The pandemic moved 
the health sciences researchers around the world to study various aspects of widespread disease. 
To know the volume and hotspots of COVID-19 research this study is prepared using the 
bibliometric method of research evaluation. Scopus and Web of Science; two most widely used 
indexing databases are used to retrieve the already published research on the COVID-19 pandemic. 
Two data sources are selected for comprehensive coverage. Health scientists have carried out 1060 
research studies on the pandemic until now. These publications have been cited with an average 
of 1.4 citations per publication. China is leading in producing COVID-19 research followed by the 
United States of America and the United Kingdom with 32%, 13%, and 6% share respectively. 
Top-ranked journals categorized in first and second quartiles are publishing most of the research 
on COVID-19. BMJ, the Lancet, and Journal of Medical Virology are the most preferred journals 
by the researchers to publish their research on COVID-19. 
Keywords 
bibliometrics, research output, research hotspot, coronavirus, novel coronavirus, COVID-19, 
2019-nCoV acute respiratory disease, SARS-CoV-2 
Introduction 
Humans are familiar with the pandemics as they have faced deadly diseases over the course of 
history; be it smallpox, cholera, influenza, plagues, HIV/AIDS, Ebola or coronavirus in current 
times. Coronavirus is a term known for group of viruses that cause respiratory diseases in humans. 
The early viruses in the family are SARS and MERS. Novel coronavirus is new addition in this 
group of viruses reported in December 2019 in China. A pneumonia of unknown cause was first 
identified in December 2019 and reported in WHO country office in China on the last day of year 
2019. The disease was detected in Wuhan in the Hubei province of China. WHO issued its 
guidance on novel coronavirus and issued a tool to countries to check their ability to detect the 
virus. China made publically available the genome sequencing of novel coronavirus opening a way 
for other countries to develop diagnostic kits. WHO declared the outbreak as public health 
emergency of international concern first at the end of January 2020 and characterized it as a 
pandemic then later on March 11, 2020 (“Coronavirus (COVID-19) events as they happen,” 2020). 
WHO recommended the interim name of the outbreak as “2019-nCoV acute respiratory disease” 
that was finally named as “COVID-19”. The virus was given the name “SARS-CoV-2” (“Naming 
the coronavirus disease (COVID-19) and the virus that causes it,” 2020). 
As of April 10, 2020, the virus has spread in the six regions of WHO named Europe, Americas, 
Western Pacific, Eastern Mediterranean, South-East Asia and Africa. There are 1.4 million 
confirmed cases of COVID-19 with more than 85000 deaths. United States of America is the most 
affected county with highest number of 0.4 million cases followed by Spain and Italy with more 
than 0.1 million confirmed cases for each (“WHO COVID-19 Dashboard,” 2020). It is feared that 
the numbers of affected people and mortalities may increase many folds in coming months.   
The COVID-19 pandemic stimulated the research community to collect, arrange and disseminate 
scientific information on new disease. Medical scientists and health specialists are working to 
describe clinical characteristics of COVID-19 patients (Chen et al., 2020; Guan et al., 2020; Hu et 
al., 2020; Jiang et al., 2020; W. Yang et al., n.d.; Zhang et al., 2020). Teams and organizations are 
doing experimentations to produce vaccination (Ahmed, Quadeer, & McKay, 2020; Dhama et al., 
2020; Liu et al., 2020; Prompetchara, Ketloy, & Palaga, 2020). Economists are estimating the 
economic impact of the pandemic and governments are allocating funds to mitigate the reverse 
effects (Anderson, Heesterbeek, & Klinkenberg, 2020; Baldwin, Weder, & Mauro, 2020; 
Fernandes, 2020; McKibbin & Fernando, 2020; Stratton, 2020). With these multifaceted 
contributions from different segments of humanity and scientific fraternity, we put our contribution 
in a different way to help the researchers in the field with the mapping of published research on 
this pandemic as scientific community is interested to know the hotspots and volume of COVID-
19 research.  
This mapping of research will help researchers to know the status of already published literature 
on COVID-19, hence, providing a reference for future studies.  Further, the study will provide 
empirical evidence to WHO and other relevant bodies to identify the countries and regions where 
the outbreak exists but no or little research is being produced. For this, we use bibliometric methods 
to map the research output on COVID-19 to answer the following research questions:  
1. What is the volume of research published on COVID-19 so far? 
2. What are the hotspots of research on COVID-19? 
3. Is this research being noticed and cited by fellow researchers? 
4. Which institutions are researching on COVID-19? 
This study is prepared with the prime objective to provide a revealing picture of peer-reviewed 
literature on the COVID-19 that has already been published in the initial months of outbreak of 
disease. The other supplementary objectives of study are:  
▪ To identify the countries and areas producing research on COVID-19. 
▪ To know the size of research on COVID-19 that has been produced so far.  
▪ To know the publication patterns of this research. 
Review of Literature  
SARS-CoV (severe acute respiratory syndrome coronavirus) and MERS-CoV (Middle East 
Respiratory Syndrome) were the earlier forms of coronavirus family of the viruses. Much scientific 
literature has been published on the outbreaks of these earlier forms of coronavirus. Several studies 
(Chiu, Huang, & Ho, 2004; Jarneving, 2007; Kostoff & SA Morse, 2011; L.-M. Yang & Yang, 
2005; Zehra, 2011; Zyoud, 2016) have been prepared to map that literature. 
COVID-19, the latest form of the coronavirus gained attention of the scientific and research 
community of the world since its early spread in China. Research studies are being carried out to 
control the pandemic. Bibliometricians have started mapping this research in order to identify the 
patterns of COVID-19 research. (LOU et al., 2020) prepared a bibliometric report to analyze the 
research output on COVID-19. Authors extracted the data from PubMed database. Study observed 
that China contributed most of the research data during the outbreak of disease. Study further 
observed that hospitals being the frontline institutions facing the pandemic are producing the 
COVID-19 research as well. More than of 40% corresponding authors were found to be affiliated 
with hospitals. (Dong et al., 2020) observed in their study that clinical characterization, 
epidemiology and virus transmission are more focused areas of research on COVID-19. Authors 
further observed that topics like vaccines, therapeutics and genomics accounted for less than 10% 
of their research on COVID-19.  
Using Science Citation Index of Web of Science database (Bonilla-Aldana et al., 2020) observed 
that USA is taking lead in publishing COVID-19 research followed by China. South Korea and 
Hong Kong contributed with 10 % of research on disease. Saudi Arabia contributed the most from 
Middle East region. (Chahrour et al., 2020) prepared a study on current status of research on 
coronavirus using PubMed database. Authors observed that Asian countries produced 77% of total 
publications on the disease. China, being the early epicenter of disease contributed the highest 
number of publications on COVID-19 research followed by United States of America.  
(Hossain, 2020) identified that genetic, epidemiological and zoonotic are major topics that are 
associated with COVID-19 research. The mean number of authors per document was 3.91, while 
the mean for citation per document was recorded as 2.47. The study observed the varying progress 
in different areas of knowledge on COVID-19 research. 
(Homolak, Kodvanj, & Virag, 2020) observed that due to overproduction of scientific data on 
COVID-19, there are possibilities of difficulties in making the information available and research 
collaborating at start of disease. Authors believed that to find solutions to control the pandemic, 
the researchers could have used the data efficiently. 
Since the scientific literature is coming fast on COVID-19 pandemic, this study tries to include the 
missed literature by previous studies by incorporating more recently published research. Most of 
the bibliometric studies have selected a single indexing database to retrieve the research 
publications. This study used Web of Science and Scopus, two most widely used indexing 
databases to retrieve results. Selection of two largest indexing and abstracting databases makes 
this study a unique of its kind with very little chance of missing any published scientific research.        
Methodology 
For this study, two largest multidisciplinary databases of peer-reviewed literature, Web of Science 
and Scopus, were used to get maximum coverage of the scholarly publications of Coronavirus 
(Covid-19) published after the burst of this pandemic. The authors used “Covid 19” as a searching 
keyword and set basic search as criteria for these two databases. The time frame was set from 
beginning to April 6, 2020 with no filter applied with the purpose to retrieve maximum number of 
records. The data was extracted by both the authors simultaneously using the double extraction 
method to check the data similarity. Both the authors reviewed the data before starting the analysis. 
Retrieval of COVID-19 records from the databases was completed within one day to avoid the 
changes in daily updates of databases. The total 1234 retrieved records from both databases 
(WOS=250, Scopus=984) were imported in Endnote Desktop software. To identify the relevant 
records, each record was checked twice by authors. 174 duplicate and irrelevant records were 
deleted. Finally, 1060 records are included in the research study. Refined 1060 records were 
exported to MS Access. The authors added some additional fields such as database name, author 
affiliation, gender and authorship types in MS Access database. Microsoft Excel, Microsoft Access 
and Endnote software were used for data analysis. 
Limitations 
The study does not cover everything that is published on COVID-19 as the disease is spreading 
fast around the world and a lot of literature is yet to be published.     
Furthermore, while the Web of Science and Scopus databases are considered to be the most 
comprehensive multidisciplinary indexing databases of peer-reviewed literature, however, the 
resources not included in these databases due to indexing and coverage policies are missed.  
The study covers COVID-19 research only. The publications on early forms of coronavirus 
diseases are not included in this study to be focused to showcase COVID-19 research only.  
Data Analysis 
1060 research studies have been conducted in the early months of COVID-19 pandemic breakout. 
Most of these research studies are carried out and are published in first quarter of the year 2020. 
Nearly three quarters of these publications are multi-authored and are collaborative efforts while 
the rest one fourth are single authored studies. Although these publications are very recent but are 
being noticed by fellow researchers due to the significance of the topic and concentration of the 
pandemic. For this reason, these research publications are receiving citations with the onset of their 
publishing. One fourth of these publications have already been cited so far at least once or more 
times. These publications have received 1487 citations with an average of 1.4 citations per 
publication till the time of this study.   
To identify the hotspots of research on COVID-19, affiliation country of contributing authors are 
identified. It was observed that authors of 80 countries are involved in conducting research on 
different aspects of COVID-19 pandemic. China is leading in producing research on COVID-19 
being the early epicenter of disease. Chinese authors have contributed nearly one third of COVID-
19 research so far. USA and UK follows China with 13% and 6% contribution respectively. These 
three countries have produced more than half of COVID-19 research collectively. Other prominent 
contributors are Italy, Taiwan, France, Singapore, South Korea, Germany, Japan, Canada, 
Australia and Switzerland. Figure 1 displays top 31 countries producing COVID-19 research with 
their number of contributing authors. 
[Figure 1. Distribution of Countries with Authors Counts] 
The study observed that research on COVID-19 is being published in top quartile journals. 
Analysis of most common 20 journals publishing COVID-19 research reveals that 70% journals 
are ranked in 1st quartile of Web of Science and Scopus databases. 20% of these journals are ranked 
in 2nd quartile. British Medical Journal -BMJ has published the highest number (118) of research 
papers with more than 11% of research output on COVID-19 followed by the Lancet and Journal 
of Medical Virology with 4.72% and 3.40% respectively in Scopus database. BMJ and the Lancet 
remained the most popular journals in Web of Science database as well with about 4% and 2% of 
total research on COVID-19 so far. Table 1 displays the most common journals publishing 
COVID-19 research. Journals quartiles, relevant impact factor and sitescore are provided.  
  
[Table 1. Top 20 Journals Publishing Research on COVID-19] 
Journal Title 
Publications Percentage Quartile Impact Factor/CiteScore 
WoS Scopus WoS Scopus WoS Scopus WoS Scopus 
BMJ-British Medical Journal 42 118 3.96 11.13 Q1 Q1 27.604 1.78 
The Lancet 18 50 1.70 4.72 Q1 Q1 59.102 10.28 
Journal of Medical Virology 6 36 0.57 3.40 Q3 Q2 2.049 1.94 
JAMA - Journal of the 
American Medical 
Association 
- 29 0.00 2.74 Q1 Q1 51.273 6.98 
Eurosurveillance 8 26 0.75 2.45 Q1 Q1 7.421 5.05 
Travel Medicine and 
Infectious Disease 
- 22 0.00 2.08 Q1 Q1 4.868 1.8 
The Lancet Infectious 
Diseases 
- 21 0.00 1.98 Q1 Q1 27.516 6.53 
Nature 3 17 0.28 1.60 Q1 Q1 43.07 15.21 
Emerging Microbes and 
Infections 
1 18 0.09 1.70 Q1 Q1 6.212 4.36 
Science 1 16 0.09 1.51 Q1 Q1 41.063 15.21 
New England Journal of 
Medicine 
1 12 0.09 1.13 Q1 Q1 16.1 70.67 
Journal of Infection - 12 0.00 1.13 Q1 Q1 5.099 3.24 
Journal of Korean Medical 
Science 
5 12 0.47 1.13 Q2 Q2 1.716 1.6 
The Lancet Respiratory 
Medicine 
 - 
11 0.00 1.04 Q1 Q1 22.992 4.91 
Infection Control and 
Hospital Epidemiology 
 - 
10 0.00 0.94 Q2 Q1 2.856 2.09 
Swiss Medical Weekly 2 9 0.19 0.85 Q2 Q2 1.821 1.49 
Journal of Microbiology, 
Immunology and Infection 
- 9 0.00 0.85 Q3 Q2 2.455 1.86 
The Lancet Global Health - 8 0.00 0.75 Q1 Q1 15.873 4.51 
Radiology - 8 0.00 0.75 Q1 Q1 7.608 5.83 
Chinese General Practice - 7 0.00 0.66 NA Q3 NA 0.07 
Figure 2 displays the indexing share of COVID-19 research in Scopus and Web of Science 
databases. Scopus database have indexed more than 90% of research on COVID-19 indicating the 
broader coverage of database. Web of Science is more selective in journals selection and has 
indexed nearly a quarter of COVID-19 research. 16% of this research is overlapped in both the 
selected databases.  
 
 
 
 
 
 
 
[Figure 2. Share of COVID-19 Research in Web of Science and Scopus Databases] 
The most active institutions producing research on the pandemic are identified by checking 
researchers’ institutional affiliations. Most of these institutions are Chines based universities and 
research institutes. Huazhong University of Science and Technology hosts the highest number 
researchers doing research on COVID19 followed by Wuhan University and Fudan University 
respectively. Table 2 displays top ten institutions involved in COVID-19 research with the number 
of affiliated authors.  
[Table 2. Top Institutes Doing Research on COVID-19] 
Institute Affiliated Authors 
Huazhong University of Science and Technology 48 
Wuhan University 39 
Fudan University 37 
Zhongnan Hospital of Wuhan University 26 
Department of Medicine 26 
Zhejiang University School of Medicine 21 
National University Health System 18 
University of Hong Kong 18 
Chinese Academy of Medical Sciences 17 
National Taiwan University College of Medicine 16 
 
The frequently used keywords are presented in Figure 3. There were 20 most used keywords in 
this list from which ‘Covid-19’ was the most frequently used keyword (N=347). Similarly, 
‘Coronavirus infection’ was used in 255 publications. The least used keyword in the list was 
‘priority journal’ that were used only in 58 publications.  
[Figure 3. Frequently used Keywords] 
Conclusion 
We expect more research on the topic of much significance and urgency as the pandemic has 
spread in almost all the regions around the world. Till the time of this study, 1060 research studies 
have been carried out on COVID-19 pandemic. These publications have been cited1487 times with 
an average of 1.4 citations per publication.  
China is leading in producing COVID-19 research with 32% of its contribution. The United States 
of America and the United Kingdom follows China with 13% and 6% of shares respectively.  
Top ranked journals categorized in first and second quartiles have published most of the research 
on COVID-19. BMJ, the Lancet and Journal of Medical Virology are the most preferred journals 
by the researchers to publish COVID-19 research.  
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